125 related articles for article (PubMed ID: 15740593)
1. FGF-2 blocks TGF-beta1-mediated suppression of Bcl-2 in normal melanocytes.
von Willebrand M; Köhler K; Alanko T; Laiho M; Saksela O
Exp Dermatol; 2005 Mar; 14(3):202-8. PubMed ID: 15740593
[TBL] [Abstract][Full Text] [Related]
2. Transforming growth factor beta1 induces apoptosis in normal melanocytes but not in nevus cells grown in type I collagen gel.
Alanko T; Saksela O
J Invest Dermatol; 2000 Aug; 115(2):286-91. PubMed ID: 10951248
[TBL] [Abstract][Full Text] [Related]
3. Desensitization of melanoma cells to autocrine TGF-beta isoforms.
Krasagakis K; Krüger-Krasagakes S; Fimmel S; Eberle J; Thölke D; von der Ohe M; Mansmann U; Orfanos CE
J Cell Physiol; 1999 Feb; 178(2):179-87. PubMed ID: 10048582
[TBL] [Abstract][Full Text] [Related]
4. FGF expression allows nevus cells to survive in three-dimensional collagen gel under conditions that induce apoptosis in normal human melanocytes.
Alanko T; Rosenberg M; Saksela O
J Invest Dermatol; 1999 Jul; 113(1):111-6. PubMed ID: 10417628
[TBL] [Abstract][Full Text] [Related]
5. Transforming growth factor-beta1 increases survival of human melanoma through stroma remodeling.
Berking C; Takemoto R; Schaider H; Showe L; Satyamoorthy K; Robbins P; Herlyn M
Cancer Res; 2001 Nov; 61(22):8306-16. PubMed ID: 11719464
[TBL] [Abstract][Full Text] [Related]
6. Fibroblast growth factor-2 maintains the differentiation potential of nucleus pulposus cells in vitro: implications for cell-based transplantation therapy.
Tsai TT; Guttapalli A; Oguz E; Chen LH; Vaccaro AR; Albert TJ; Shapiro IM; Risbud MV
Spine (Phila Pa 1976); 2007 Mar; 32(5):495-502. PubMed ID: 17334282
[TBL] [Abstract][Full Text] [Related]
7. Transforming growth factor beta production and responsiveness in normal human melanocytes and melanoma cells.
Rodeck U; Bossler A; Graeven U; Fox FE; Nowell PC; Knabbe C; Kari C
Cancer Res; 1994 Jan; 54(2):575-81. PubMed ID: 8275496
[TBL] [Abstract][Full Text] [Related]
8. The effect of growth factor signaling on keratocytes in vitro and its relationship to the phases of stromal wound repair.
Etheredge L; Kane BP; Hassell JR
Invest Ophthalmol Vis Sci; 2009 Jul; 50(7):3128-36. PubMed ID: 19234354
[TBL] [Abstract][Full Text] [Related]
9. Transcriptional regulation of plasminogen activator inhibitor-1 by transforming growth factor-beta, activin A and microphthalmia-associated transcription factor.
Murakami M; Ikeda T; Saito T; Ogawa K; Nishino Y; Nakaya K; Funaba M
Cell Signal; 2006 Feb; 18(2):256-65. PubMed ID: 15961275
[TBL] [Abstract][Full Text] [Related]
10. Sprouty2 downregulation plays a pivotal role in mediating crosstalk between TGF-beta1 signaling and EGF as well as FGF receptor tyrosine kinase-ERK pathways in mesenchymal cells.
Ding W; Shi W; Bellusci S; Groffen J; Heisterkamp N; Minoo P; Warburton D
J Cell Physiol; 2007 Sep; 212(3):796-806. PubMed ID: 17516543
[TBL] [Abstract][Full Text] [Related]
11. Ethanol induces apoptotic death of developing beta-endorphin neurons via suppression of cyclic adenosine monophosphate production and activation of transforming growth factor-beta1-linked apoptotic signaling.
Chen CP; Kuhn P; Chaturvedi K; Boyadjieva N; Sarkar DK
Mol Pharmacol; 2006 Mar; 69(3):706-17. PubMed ID: 16326933
[TBL] [Abstract][Full Text] [Related]
12. Loss of functional transforming growth factor (TGF)-beta type II receptor results in insensitivity to TGF-beta1-mediated apoptosis and Epstein-Barr virus reactivation.
Fukuda M; Kurosaki H; Sairenji T
J Med Virol; 2006 Nov; 78(11):1456-64. PubMed ID: 16998876
[TBL] [Abstract][Full Text] [Related]
13. VEGF regulates FGF-2 and TGF-beta1 expression in injury endothelial cells and mediates smooth muscle cells proliferation and migration.
Li D; Zhang C; Song F; Lubenec I; Tian Y; Song QH
Microvasc Res; 2009 Mar; 77(2):134-42. PubMed ID: 18948122
[TBL] [Abstract][Full Text] [Related]
14. Balance of pro-apoptotic transforming growth factor-beta and anti-apoptotic insulin effects in the control of cell death in the postnatal mouse retina.
Duenker N; Valenciano AI; Franke A; Hernández-Sánchez C; Dressel R; Behrendt M; De Pablo F; Krieglstein K; de la Rosa EJ
Eur J Neurosci; 2005 Jul; 22(1):28-38. PubMed ID: 16029193
[TBL] [Abstract][Full Text] [Related]
15. Co-ordination of TGF-beta and FGF signaling pathways in bone organ cultures.
Mukherjee A; Dong SS; Clemens T; Alvarez J; Serra R
Mech Dev; 2005 Apr; 122(4):557-71. PubMed ID: 15804568
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
17. Possible involvement of bcl-2 in regulation of cell-cycle progression of haemopoietic cells by transforming growth factor-beta1.
Mahmud N; Katayama N; Nishii K; Sugawara T; Komada Y; Mitani H; Araki H; Ohishi K; Watanabe M; Masuya M; Nishikawa M; Minami N; Ohashi H; Shiku H
Br J Haematol; 1999 May; 105(2):470-7. PubMed ID: 10233423
[TBL] [Abstract][Full Text] [Related]
18. Independent regulation of tyrosinase by the hypopigmenting cytokines TGF beta1 and TNF alpha and the melanogenic hormone alpha-MSH in B16 mouse melanocytes.
Martínez-Esparza M; Solano F; García-Borrón JC
Cell Mol Biol (Noisy-le-grand); 1999 Nov; 45(7):991-1000. PubMed ID: 10644003
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional deregulation of VEGF, FGF2, TGF-beta1, 2, 3 and cognate receptors in breast tumorigenesis.
Soufla G; Porichis F; Sourvinos G; Vassilaros S; Spandidos DA
Cancer Lett; 2006 Apr; 235(1):100-13. PubMed ID: 15949894
[TBL] [Abstract][Full Text] [Related]
20. Role for TGF-beta1, FGF-2 and PDGF-AA in a myelination of CNS aggregate cultures enriched with macrophages.
Diemel LT; Jackson SJ; Cuzner ML
J Neurosci Res; 2003 Dec; 74(6):858-67. PubMed ID: 14648590
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
